Cross-regulation between β 1- and β 3- adrenoceptors following chronic β-adrenergic stimulation in neonatal rat cardiomyocytes

British Journal of Pharmacology

Volumn 158, Issue 1, 2009, Pages 300-313

  Ufer, Christoph ^a,c   Germack, Renée ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

1 adrenoceptor; 2 adrenoceptor; 3 adrenoceptors; Akt; CAMP accumulation; Cardiomyocytes; Down regulation; Heart; MAP kinases; Up regulation

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; CL 3162436243; CYCLIC AMP; DOBUTAMINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROCATEROL; PROTEIN KINASE; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVATION; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADRENERGIC AGONISTS; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-3;

EID: 69249216476     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00328.x     Document Type: Article

References (49)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Barbier J, Rannou-Bekono F, Marchais J, Tanguy S, Carre F (2007). Alteration of beta(3)-adrenoceptors expression and their myocardial functional effects in physiological model of chronic exercise-induced cardiac hypertrophy. Mol Cell Biochem 300 : 69 75.
3. Bensaid M, Kaghad M, Rodriguez M, Le Fur G, Caput D (1993). The rat beta 3-adrenergic receptor gene contains an intron. FEBS Lett 318 : 223 226.
4. 3-adrenergic receptor in the failing canine myocardium. Circ Res 89 : 599 606.
5. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS et al. (1984). Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 : 819 823.
6. Diebold Y, Ríos JD, Hodges RR, Rawe I, Dartt DA (2001). Presence of nerves and their receptors in mouse and human conjunctival goblet cells. Invest Ophthalmol Vis Sci 42 : 2270 2282.
7. 3-adrenoceptors in rat hearts. Diabetes 50 : 455 461.
8. Dzimiri N (1999). Regulation of β-adrenoceptor signalling in cardiac function and disease. Pharmacol Rev 51 : 465 501.
9. Edmunds JW, Mahadevan LC (2004). MAP kinases as structural adaptors and enzymatic activators in transcription complexes. J Cell Sci 117 : 3715 3723.
10. El-Armouche A, Zolk O, Rau T, Eschenhagen T (2003). Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc Res 60 : 478 487.
11. Gerhardt CC, Gros J, Strosberg AD, Issad T (1998). Stimulation of the extracellular signal-regulated kinase 1/12 patway by human beta-3 adrenergic receptor: new [pharmacological profile and mechanism of action. Mol Pharmacol 55 : 255 262.
12. 3- adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes. J Pharmacol Exp Ther 316 : 392 402.
13. 1- and β2-adrenergic receptors. Cellular Signalling 17 : 49 58.
14. Headley VV, Tanveer R, Greene SM, Zweifach A, Port JD (2004). Reciprocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition. Mol Cell Biochem 258 : 109 119.
15. Kim N, Kim H, Youm JB, Park WS, Warda M, Ko JH et al. (2006). Site specific activation of ras/raf/ERK signalling in rabbit isoproterenol-induced left ventricular hypertrophy. BBA 1763 : 1067 1075.
16. 3-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation 104 : 2485 2491.
17. Kompa AR, Gu XH, Evans BA, Summers RJ (1999). Desensitization of cardiac β-adrenoceptor signalling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins. J Mol Cell Cardiol 31 : 1185 1201.
18. Lemire I, Allen BG, Rindt H, Hebert TE (1998). Cardiac-specific overexpression of alpha1BAR regulates betaAR activity via molecular crosstalk. J Mol Cell Cardiol 30 : 1827 1839.
19. Li Z, Vaidya VA, Alvaro JD, Iredale PA, HS UR, Hoffman G et al. (1998). Protein kinase C-mediated down-regulation of β1-adrenergic receptor gene expression in rat C6 glioma cells. Mol Pharmacol 54 : 14 21.
20. Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC (2005). A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med 11 : 952 958.
21. Matsui T, Rosenzweig A (2005). Convergent signal transduction pathways controlling survival and function: the role of PI3-kinase and Akt. J Mol Cell Cardiol 38 : 63 71.
22. 3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103 : 1649 1655.
23. Moniotte S, Belge C, Sekkali B, Massion PB, Rozec B, Dessy C et al. (2007). Sepsis is associated with an upregulation of functional beta3 adrenoceptors in the myocardium. Eur J Heart Fail 9 : 1163 1171.
24. 3-adrenoceptor activation contributes to left ventricular and cardiomyocytes dysfunction in heart failure. Am J Physiol 286 : H2425 H2433.
25. Morisco C, Marrone C, Galeotti J, Shao D, Vatner DE, Vatner SF et al. (2008). Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes. Cardiovasc Res 78 : 36 44.
26. Muller-Werdan U, Buerke M, Ebelt H, Heinroth KM, Herklotz A, Loppnow H et al. (2006). Septic cardiomyopathy - a not yet discovered cardiomyopathy? Exp Clin Cardiol 11 : 226 236.
27. Naga Prasad SV, Barak LS, Rapacciuolo A, Caron MG, Rockman HA (2001). Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1: a role in receptor sequestration. J Biol Chem 276 : 18953 18959.
28. Nienaber JJ, Tachibana H, Naga Prasad SV, Esposito G, Wu D, Mao L et al. (2003). Inhibition of receptor-localized PI3K preserves cardiac β-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112 : 1067 1079.
29. Pagliari R, Peyrin L (1995). Physical conditioning in rat's influences the central and peripheral catecholamine responses to sustained exercise. Eur J Appl Physiol Occup Physiol 71 : 41 52.
30. Palfi A, Toth A, Kulcsar G, Hanto K, Deres P, Bartha E, Halmosi R et al. (2005). The role of Akt and mitogen-activated protein kinase systems in protective effect of Poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. J Pharmacol Exp Ther 315 : 273 282.
31. 1-adrenergic receptor. J Clin Invest 117 : 1335 1343.
32. Rau T, Nose M, Remmers U, Weil J, Weissmüller A, Davia K (2003) Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes. FASEB J 17 : 523 525.
33. Ribas C, Penela P, Murga C, Salcedo A, García-Hoz C, Jurado-Pueyo M et al. (2007). The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 1768 : 913 922.
34. Reithmann C, Gierschik P, Müller U, Werdan K, Jakobs KH (1990). Pseudomonas exotoxin A prevents beta-adrenoceptor-induced up-regulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells. Mol Pharmacol 37 : 631 638.
35. 2-adrenergic receptors regulate cystic fibrosis transmembrane conductance regulator activity via a new pathway involving the mitogen-activated protein kinases extracellular signal-regulated kinases. Mol Pharmacol 67 : 648 654.
36. Robidoux J, Kumar N, Daniel KW, Moukdar F, Cyr M, Medvedev AV et al. (2006). Maximal beta3-adrenergic regulation of lipolysis involves Src and epidermal growth factor receptor-dependent ERK1/2 activation. J Biol Chem 281 : 37794 37802.
37. 3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111 : 652 673.
38. Salazar NC, Chen J, Rockman HA (2007). Cardiac GPCRs: GPCR signalling in healthy and failing hearts. Biochim Biophys Acta 1768 : 1006 1018.
39. Schwartz DD, Naff BP (1997). Activation of protein kinase C by angiotensin II decreases beta 1-adrenergic receptor responsiveness in the rat heart. J Cardiovasc Pharmacol 29 : 257 264.
40. Silverman HJ, Penaranda R, Orens JB, Lee NH (1993). Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 21 : 31 39.
41. 3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J Biol Chem 17 : 12017 12022.
42. 3-adrenergic receptor gene. J Biol Chem 270 : 29483 29492.
43. 3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci USA 89 : 4490 4494.
44. Tilley DG, Rockman HA (2006). Role of β-adrenergic receptor signalling and desensitization in heart failure: new concepts and prospects for treatment. Expert Rev Cardiovasc Ther 4 : 417 432.
45. Toker A, Cantley LC (1997). Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387 : 673 676.
46. Xiao RP, Zhang SJ, Chakir K, Avdonin P, Zhu W, Bond RA et al. (2003). Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR) - but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts. Circulation 108 : 1633 1639.
47. Yoshida T, Sakane N, Wakabayashi Y, Umekawa T, Kondo M (1994). Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in yellow KK mice. Life Sci 54 : 491 498.
48. 3-adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther 315 : 1203 1211.
49. 2-adrenergic receptor subtypes optimises β-adrenergic modulation of cardiac contractility. Circ Res 97 : 244 251.